serial transplantation of adult t cell leukemia cells into severe combined immunodeficient mice.

NLM AIDSLINE Serial transplantation of adult T cell leukemia cells into severe combined immunodeficient mice. Imada K; Takaori-Kondo A; Sawada H; Imura A; Kawamata S; Okuma M;
February 28, 1997

Jpn J Cancer Res. 1996 Sep;87(9):887-92. Unique Identifier : AIDSLINE The precise mechanism of the neoplastic cell growth of adult T cell leukemia (ATL) still remains unclear. In the present study, we have succeeded in serial transplantation of ATL cells from a patient into severe combined immunodeficient (SCID) mice. In this model, we found that only a leukemic cell clone from an ATL patient could be successively transplanted into SCID mice, although it was difficult to maintain leukemic cell clones in vitro, suggesting that the microenvironment provided by SCID mice is suitable for leukemic cell growth. We could not detect human T cell leukemia virus type I (HTLV-I) mRNA or interleukin 2 (IL-2) mRNA in either the tumor cells growing in mice or the original leukemic cells. Thus, it appears that neither HTLV-I viral expression nor the IL-2 autocrine mechanism is directly involved in the neoplastic cell growth of fresh ATL cells as well as HTLV-I-infected cell lines, at least in SCID mice. In addition, we could passage frozen cells and obtain a large number of expanded leukemic cells in this model. Such a serial transplantation model, which can avoid the changes in the nature of leukemic cells that are frequently observed in in vitro culture, and which can propagate leukemic cell clones, would be very suitable not only to study the mechanism of neoplastic cell growth, but also to test potential therapeutic agents for ATL. Aged Animal Cell Division/PHYSIOLOGY Disease Models, Animal DNA, Neoplasm/ANALYSIS Female Flow Cytometry Human HTLV-I/GENETICS/METABOLISM Interleukin-2/GENETICS/METABOLISM Leukemia, T-Cell/*PATHOLOGY Mice Mice, SCID Neoplasm Transplantation Polymerase Chain Reaction RNA, Messenger/ANALYSIS Support, Non-U.S. Gov't Transcription, Genetic Transplantation, Heterologous JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 After a decade, global AIDS program looks ahead General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region HarborPath Receives $250,000 Elton John AIDS Foundation Grant to Support Program Expansion CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance CONNECTICUT: At Hartford Public High School, A Day Reserved for 'Healthy Relationships' ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment KENYA: Kenya Launches Universal HPV Vaccine Access to Youths UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Experimental Gilead drug effective in early-stage leukemia trial KENTUCKY: Northern Kentucky Health Department Ready to Give Low-Cost Hepatitis B Vaccines to Adults All teens and adults ages 15-65 should be screened for HIV Task force calls for routine HIV testing for all adults Wife killed over HIV fear along with adult son, police say BELGIUM: Long-Term Suppression of Viral Load and Sustained CD4 Cell Increase Reduce Risk of Cervical HPV Infection for HIV-Positive Women Assembly panel approves requiring condoms for adult film actors Agency Reviews Patent Application Approval Request for "Methods for Treatment of HIV and Other Infections Using a T Cell Or Viral Activator and Anti-Retroviral Combination Therapy"
Information in this article was accurate in February 28, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.